(Q53938520)

English

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

0 references

1 reference

based on heuristic

inferred from title

familial combined hyperlipidemia

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

D Zambón

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Rodriguez-Villar

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Vázquez

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Sanllehy

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

E Casals

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J M Sol

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Hernández

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

47-54

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Nicotinic acid for the treatment of hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Fibric acids: effects on lipids and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Plasma triglyceride determines structure-composition in low and high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Serum lipoproteins, apolipoproteins and very low density lipoprotein subfractions during 6-month fibrate treatment in primary hypertriglyceridaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Combination drug therapy for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Management of primary mixed hyperlipidemia with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

Familial combined hyperlipidemia and abnormal lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990009-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0026-0495(99)90009-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920144%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53938520&oldid=1527023964"